Wednesday, 16 August 2017

India News

  • Baxter erects global R&D center at Syngene

    India |  News | By BioSpectrum Bureau | 0 Comment | 05 Feb, 2014

    Bangalore: Baxter has constructed its R&D center at Biocon's Syngene facility. The facility, which was developed as a collaborative effort between the two organizations, has been name...Read more

  • India's Biological E to buy French Valneva's CMO unit

    India |  News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2013

    Singapore: France-based biotech firm Valneva is selling its clinical manufacturing operations (CMO) in Nantes to India-based Biological E. The sale of this unit, which is dedicated to the ...Read more

  • Lupin gets 16 FDA nods, launches 11 products front

    India |  Analysis | By Amrita Tejasvi | 0 Comment | 04 Jun, 2013

    US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FDA and launched 11 products during 2012. Besides building a strong gri...Read more

  • FDA approves Sun Pharma's generic Prandin

    India |  Regulatory | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2013

    Singapore: The US Food and Drug Administration (FDA) has given its finally approval to India's Sun Pharmaceutical Industries for releasing its diabetes generic Prandin. Making the announce...Read more

  • Singapore's Fortis Surgical Hospital is now Concord Medical Services

    India |  News | By BioSpectrum Bureau | 0 Comment | 16 Oct, 2015

    Singapore: Concord Medical Services, China based hospital management solution provider, has received Singapore's approval to change the name of the Fortis Surgical Hospital, which was acqui...Read more

  • Cipla, Alembic contest Indian drug pricing in court

    India |  News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013

    Singapore: Miffed at Indian government's move to slash prices of essential medicines through the new drug pricing policy, drug makers Cipla and Alembic have now moved court. The Indian gov...Read more

  • India's AYUSH becomes popular in Asia

    India |  News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2015

    Singapore: With the ancient Indian medicine systems AYUSH (Ayurveda, Yoga, Unani, Siddha and Homeopathy) gaining popularity in Asian countries, the Ministry of AYUSH is receiving requests t...Read more

  • Quintiles and Biogen Idec ink pact

    India |  News | By BioSpectrum Bureau | 0 Comment | 05 May, 2014

    Singapore: Quintiles and US-based biotech company Biogen Idec have entered into a five-year strategic clinical development agreement. The multi-year collaboration is designed to leverage t...Read more

  • Biocon launches world's first Biosimilar 'CANMAb' in India

    India |  News | By BioSpectrum Bureau | 0 Comment | 20 Jan, 2014

    Bangalore: CANMAb has been jointly developed by Biocon in partnership with Mylan and it is said to be the world's first biosimilar version of Herceptin. At the launch this morning, Dr Kira...Read more

  • Piramal to acquire US-based Decision Resource Group

    India |  News | By BioSpectrum Bureau | 0 Comment | 17 May, 2012

    Mumbai: Piramal Healthcare, an innovation led company, has agreed to acquire Decision Resources Group (DRG) a US-based company in the healthcare information segment, from Providence Equity ...Read more

  • Cadila Healthcare eyeing US, Europe markets

    India |  News | By BioSpectrum Bureau | 0 Comment | 15 Sep, 2014

    Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon start filings for approval of its innovator drug Lipaglyn there. As per ...Read more

  • Indian drug dealers worried about $1.69 bn old stocks

    India |  News | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013

    New Delhi: Ahead of the Drug Price Control Order (DPCO) to revise drug prices that came into effect on July 29, medicine wholesalers and retailers have warned of many repercussions. The mos...Read more

  • Dr Reddy's launch cystic acne generic Zenatane

    India |  News | By BioSpectrum Bureau | 0 Comment | 02 Apr, 2013

    Hyderabad: Dr. Reddy's Laboratories launched Zenatane (isotretinoin) capsules in 20 mg and 40 mg in the US. The drug is a therapeutically equivalent generic version of Accutane. The drug...Read more

  • Transasia gets award from the President of India

    India |  News | By BioSpectrum Bureau | 0 Comment | 26 Oct, 2012

    New Delhi: Transasia BioMedicals, one of India's largest IVD companies, was recently conferred with the coveted 'Niryat Shree' Gold trophy by the President of India, Pranab Mukherjee . Inst...Read more

  • FIPB approves investments worth $143.43 mn

    India |  News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2013

    Singapore: The Foreign Investment Promotion Board (FIPB) in India cleared six investment proposals in the pharmaceutical sector on July 29. The total worth of the projects that were cleared...Read more

  • Dr. Reddy's generic of Revatio (sildenafil) now available in US

    India |  News | By BioSpectrum Bureau | 0 Comment | 20 Nov, 2012

    Hyderabad: Dr. Reddy's Laboratories has launched sildenafil tablets (20 mg), a bioequivalent generic version of Revatio tablets in the US market. Revatio is indicated for the treatment of...Read more

  • First generic versions of Cymbalta receive FDA nod

    India |  Regulatory | By BioSpectrum Bureau | 0 Comment | 13 Dec, 2013

    Singapore: US Food and Drug Administration has approved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and ot...Read more

  • Sri Lanka again bans drug imports from Indian firms

    India |  News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2013

    Singapore: Sri Lanka's Ministry of Health has decided to ban the purchase of drugs from four Indian pharmaceutical companies, including Laborate, Vivek, Bafna and Elysium Pharma, due to inc...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls